These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2071257)

  • 1. Effect of L-alpha-glyceryl-phosphorylcholine on amnesia caused by scopolamine.
    Canal N; Franceschi M; Alberoni M; Castiglioni C; De Moliner P; Longoni A
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):103-7. PubMed ID: 2071257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-alpha-glycerylphosphorylcholine antagonizes scopolamine-induced amnesia and enhances hippocampal cholinergic transmission in the rat.
    Sigala S; Imperato A; Rizzonelli P; Casolini P; Missale C; Spano P
    Eur J Pharmacol; 1992 Feb; 211(3):351-8. PubMed ID: 1319912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acute doses of oxiracetam in the scopolamine model of human amnesia.
    Preda L; Alberoni M; Bressi S; Cattaneo C; Parini J; Canal N; Franceschi M
    Psychopharmacology (Berl); 1993; 110(4):421-6. PubMed ID: 7870912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scopolamine-induced amnesia can be prevented by heat shock pretreatment in rats.
    Hung CH; Lin MT; Liao JF; Wang JJ
    Neurosci Lett; 2004 Jul; 364(2):63-6. PubMed ID: 15196678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anterograde amnesia with oral lorazepam.
    Mac DS; Kumar R; Goodwin DW
    J Clin Psychiatry; 1985 Apr; 46(4):137-8. PubMed ID: 3980452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs, memory, and metamemory: a dose-effect study with lorazepam and scopolamine.
    Mintzer MZ; Griffiths RR
    Exp Clin Psychopharmacol; 2005 Nov; 13(4):336-47. PubMed ID: 16366764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine brain phosphatidylserine attenuates scopolamine induced amnesia in mice.
    Claro FT; Patti CL; Abílio VC; Frussa-Filho R; Silva RH
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):881-6. PubMed ID: 16624469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative analysis of scopolamine-induced amnesia.
    Caine ED; Weingartner H; Ludlow CL; Cudahy EA; Wehry S
    Psychopharmacology (Berl); 1981; 74(1):74-80. PubMed ID: 6791209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
    Otmani S; Demazières A; Staner C; Jacob N; Nir T; Zisapel N; Staner L
    Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scopolamine bioavailability in combined oral and transdermal delivery.
    Nachum Z; Shahal B; Shupak A; Spitzer O; Gonen A; Beiran I; Lavon H; Eynan M; Dachir S; Levy A
    J Pharmacol Exp Ther; 2001 Jan; 296(1):121-3. PubMed ID: 11123371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estradiol treatment and its interaction with the cholinergic system: effects on cognitive function in healthy young women.
    Bartholomeusz CF; Wesnes KA; Kulkarni J; Vitetta L; Croft RJ; Nathan PJ
    Horm Behav; 2008 Nov; 54(5):684-93. PubMed ID: 18706905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gomisin A improves scopolamine-induced memory impairment in mice.
    Kim DH; Hung TM; Bae KH; Jung JW; Lee S; Yoon BH; Cheong JH; Ko KH; Ryu JH
    Eur J Pharmacol; 2006 Aug; 542(1-3):129-35. PubMed ID: 16824513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scopolamine induced deficits in a battery of rat cognitive tests: comparisons of sensitivity and specificity.
    Hodges DB; Lindner MD; Hogan JB; Jones KM; Markus EJ
    Behav Pharmacol; 2009 May; 20(3):237-51. PubMed ID: 19436198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of clorazepate, diazepam, lorazepam, and placebo on human memory.
    Healey M; Pickens R; Meisch R; McKenna T
    J Clin Psychiatry; 1983 Dec; 44(12):436-9. PubMed ID: 6140261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone in electroconvulsive therapy: efficacy for depression and post-ECT amnesia.
    Horne RL; Pettinati HM; Menken M; Sugerman AA; Varga E; Wilson GF
    Biol Psychiatry; 1984 Jan; 19(1):13-27. PubMed ID: 6704458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of BT-11 on memory in healthy humans.
    Lee JY; Kim KY; Shin KY; Won BY; Jung HY; Suh YH
    Neurosci Lett; 2009 Apr; 454(2):111-4. PubMed ID: 19429065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine H1-receptor blockade in humans affects psychomotor performance but not memory.
    van Ruitenbeek P; Vermeeren A; Riedel W
    J Psychopharmacol; 2008 Aug; 22(6):663-72. PubMed ID: 18208925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticholinergic drugs: effects on oxygen consumption and energy expenditure.
    Kirvelä OA; Kanto JH; Räty HM; Iisalo E
    Anesth Analg; 1994 May; 78(5):995-9. PubMed ID: 8161002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB
    Hum Psychopharmacol; 2007 Dec; 22(8):559-66. PubMed ID: 17902186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of effect sizes to characterize the nature of cognitive change in psychopharmacological studies: an example with scopolamine.
    Fredrickson A; Snyder PJ; Cromer J; Thomas E; Lewis M; Maruff P
    Hum Psychopharmacol; 2008 Jul; 23(5):425-36. PubMed ID: 18421801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.